{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:40:10Z","timestamp":1788910810261,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T00:00:00Z","timestamp":1693612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T00:00:00Z","timestamp":1693612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Key Project of the Natural Science Foundation of Anhui Provincial Educational Department","award":["KJ2020A0620"],"award-info":[{"award-number":["KJ2020A0620"]}]},{"name":"the Key Project of the Natural Science Foundation of Anhui Provincial Educational Department","award":["KJ2020A0620"],"award-info":[{"award-number":["KJ2020A0620"]}]},{"name":"the Key Project of the Natural Science Foundation of Anhui Provincial Educational Department","award":["KJ2020A0620"],"award-info":[{"award-number":["KJ2020A0620"]}]},{"name":"the Key Project of the Natural Science Foundation of Anhui Provincial Educational Department","award":["KJ2020A0620"],"award-info":[{"award-number":["KJ2020A0620"]}]},{"name":"the Key Project of the Natural Science Foundation of Anhui Provincial Educational Department","award":["KJ2020A0620"],"award-info":[{"award-number":["KJ2020A0620"]}]},{"name":"the Key Project of the Natural Science Foundation of Anhui Provincial Educational Department","award":["KJ2020A0620"],"award-info":[{"award-number":["KJ2020A0620"]}]},{"name":"the Key Project of the Natural Science Foundation of Anhui Provincial Educational Department","award":["KJ2020A0620"],"award-info":[{"award-number":["KJ2020A0620"]}]},{"name":"the Key Project of the Natural Science Foundation of Anhui Provincial Educational Department","award":["KJ2020A0620"],"award-info":[{"award-number":["KJ2020A0620"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Opa interacting protein 5 (OIP5), which is a cancer\/testis-specific gene, plays a cancer-promoting role in various types of human cancer. However, the role of OIP5 in the carcinogenesis and progression of ovarian cancer remains unknown.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We first analyzed the expression of OIP5 in ovarian cancer and various human tumors with the Sangerbox online analysis tool. GSE12470, GSE14407 and GSE54388 were downloaded from the Gene Expression Omnibus (GEO) database, and GEO2R was used to screen differentially expressed genes in ovarian cancer tissues. Gene Ontology (GO) enrichment analysis was used to explore the related biological processes. Receiver operating characteristic (ROC) curve was generated to evaluate the predictive ability of OIP5 for ovarian cancer. Next, RT\u2013PCR, immunohistochemistry and Western blotting were utilized to evaluate the expression of OIP5 in ovarian cancer. CCK8, EdU proliferation assays and colony formation assays were used to measure cell proliferation, cell cycle progression was examined by PI staining and flow cytometry, and cell apoptosis was examined by Caspase3\/7 activity assays. The effect of OIP5 on the migration and invasion of ovarian cancer cells was analyzed with Transwell assays.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We found that OIP5 is highly expressed in ovarian cancer through bioinformatics analysis, and importantly, OIP5 may be an important biomarker for the prognosis and diagnosis of ovarian cancer. RT\u2013PCR assays, immunohistochemistry and Western blotting were also used to confirm the high expression of OIP5 in ovarian cancer. Subsequently, we demonstrated that the proliferation and migration of the ovarian cancer cell line A2780 were significantly inhibited after OIP5 gene silencing, apoptosis was increased and cell cycle progression was arrested at the G1 phase.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study indicated that OIP5 was highly expressed in ovarian cancer and that downregulation of OIP5 inhibited the proliferation, migration and invasion of ovarian cancer cells, induced cell cycle arrest and promoted cell apoptosis. Therefore, OIP5 may be an important biomarker for the early diagnosis and potential target for treatment of ovarian cancer.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13048-023-01265-4","type":"journal-article","created":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T10:01:52Z","timestamp":1693648912000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The role of OIP5 in the carcinogenesis and progression of ovarian cancer"],"prefix":"10.1186","volume":"16","author":[{"given":"Xin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiqin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renjie","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Likai","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiechen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,2]]},"reference":[{"issue":"2","key":"1265_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.soncn.2019.02.001","volume":"35","author":"C Stewart","year":"2019","unstructured":"Stewart C, Ralyea C, Lockwood S. Ovarian Cancer: an Integrated Review. Semin Oncol Nurs. 2019;35(2):151\u20136.","journal-title":"Semin Oncol Nurs"},{"issue":"5","key":"1265_CR2","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","volume":"135","author":"C Xia","year":"2022","unstructured":"Xia C, Dong X, Li H, Cao M, Sun D, He S, Yang F, Yan X, Zhang S, Li N, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J (Engl). 2022;135(5):584\u201390.","journal-title":"Chin Med J (Engl)"},{"key":"1265_CR3","doi-asserted-by":"publisher","first-page":"m3773","DOI":"10.1136\/bmj.m3773","volume":"371","author":"L Kuroki","year":"2020","unstructured":"Kuroki L, Guntupalli SR. Treatment of epithelial ovarian cancer. BMJ. 2020;371:m3773.","journal-title":"BMJ"},{"key":"1265_CR4","doi-asserted-by":"publisher","first-page":"577869","DOI":"10.3389\/fimmu.2020.577869","volume":"11","author":"C Yang","year":"2020","unstructured":"Yang C, Xia BR, Zhang ZC, Zhang YJ, Lou G, Jin WL. Immunotherapy for Ovarian Cancer: adjuvant, combination, and Neoadjuvant. Front Immunol. 2020;11:577869.","journal-title":"Front Immunol"},{"key":"1265_CR5","doi-asserted-by":"crossref","unstructured":"Morand S, Devanaboyina M, Staats H, Stanbery L, Nemunaitis J. Ovarian Cancer Immunotherapy and Personalized Medicine. Int J Mol Sci 2021, 22(12).","DOI":"10.3390\/ijms22126532"},{"issue":"1","key":"1265_CR6","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s12253-017-0313-4","volume":"25","author":"M Afsharpad","year":"2019","unstructured":"Afsharpad M, Nowroozi MR, Mobasheri MB, Ayati M, Nekoohesh L, Saffari M, Zendehdel K, Modarressi MH. Cancer-testis antigens as new candidate diagnostic biomarkers for transitional cell carcinoma of bladder. Pathol Oncol Res. 2019;25(1):191\u20139.","journal-title":"Pathol Oncol Res"},{"issue":"1","key":"1265_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.devcel.2006.11.002","volume":"12","author":"Y Fujita","year":"2007","unstructured":"Fujita Y, Hayashi T, Kiyomitsu T, Toyoda Y, Kokubu A, Obuse C, Yanagida M. Priming of centromere for CENP-A recruitment by human hMis18alpha, hMis18beta, and M18BP1. Dev Cell. 2007;12(1):17\u201330.","journal-title":"Dev Cell"},{"issue":"Pt 5","key":"1265_CR8","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1242\/jcs.03390","volume":"120","author":"N Naetar","year":"2007","unstructured":"Naetar N, Hutter S, Dorner D, Dechat T, Korbei B, Gotzmann J, Beug H, Foisner R. LAP2alpha-binding protein LINT-25 is a novel chromatin-associated protein involved in cell cycle exit. J Cell Sci. 2007;120(Pt 5):737\u201347.","journal-title":"J Cell Sci"},{"issue":"10","key":"1265_CR9","doi-asserted-by":"publisher","first-page":"101042831773398","DOI":"10.1177\/1010428317733985","volume":"39","author":"TW Kim","year":"2017","unstructured":"Kim TW, Lee SJ, Park YJ, Park SY, Oh BM, Park YS, Kim BY, Lee YH, Cho HJ, Yoon SR, et al. Opa-interacting protein 5 modulates docetaxel-induced cell death via regulation of mitophagy in gastric cancer. Tumour Biol. 2017;39(10):1010428317733985.","journal-title":"Tumour Biol"},{"key":"1265_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2016.11.046","volume":"603","author":"HC Li","year":"2017","unstructured":"Li HC, Chen YF, Feng W, Cai H, Mei Y, Jiang YM, Chen T, Xu K, Feng DX. Loss of the Opa interacting protein 5 inhibits breast cancer proliferation through miR-139-5p\/NOTCH1 pathway. Gene. 2017;603:1\u20138.","journal-title":"Gene"},{"issue":"9","key":"1265_CR11","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1093\/neuonc\/noy037","volume":"20","author":"J He","year":"2018","unstructured":"He J, Zhao Y, Zhao E, Wang X, Dong Z, Chen Y, Yang L, Cui H. Cancer-testis specific gene OIP5: a downstream gene of E2F1 that promotes tumorigenesis and metastasis in glioblastoma by stabilizing E2F1 signaling. Neuro Oncol. 2018;20(9):1173\u201384.","journal-title":"Neuro Oncol"},{"key":"1265_CR12","doi-asserted-by":"crossref","unstructured":"Li H, Zhang J, Lee M, Yu G, Han X, Kim D. OIP5, a target of miR-15b-5p, regulates hepatocellular carcinoma growth and metastasis through the AKT\/mTORC1 and \u03b2-catenin signaling pathways. Oncotarget 2017.","DOI":"10.18632\/oncotarget.15185"},{"issue":"11","key":"1265_CR13","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1007\/s00432-017-2485-4","volume":"143","author":"X He","year":"2017","unstructured":"He X, Hou J, Ping J, Wen D, He J. Opa interacting protein 5 acts as an oncogene in bladder cancer. J Cancer Res Clin Oncol. 2017;143(11):2221\u201333.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"1265_CR14","first-page":"2075","volume":"41","author":"Y Li","year":"2019","unstructured":"Li Y, Xiao F, Li W, Hu P, Xu R, Li J, Li G, Zhu C. Overexpression of Opa interacting protein 5 increases the progression of liver cancer via BMPR2\/JUN\/CHEK1\/RAC1 dysregulation. Oncol Rep. 2019;41(4):2075\u201388.","journal-title":"Oncol Rep"},{"issue":"3","key":"1265_CR15","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/j.1349-7006.2011.02167.x","volume":"103","author":"J Koinuma","year":"2012","unstructured":"Koinuma J, Akiyama H, Fujita M, Hosokawa M, Tsuchiya E, Kondo S, Nakamura Y, Daigo Y. Characterization of an Opa interacting protein 5 involved in lung and esophageal carcinogenesis. Cancer Sci. 2012;103(3):577\u201386.","journal-title":"Cancer Sci"},{"issue":"1","key":"1265_CR16","doi-asserted-by":"publisher","first-page":"6298","DOI":"10.1038\/s41467-020-20140-0","volume":"11","author":"M Song","year":"2020","unstructured":"Song M, Yeku OO, Rafiq S, Purdon T, Dong X, Zhu L, Zhang T, Wang H, Yu Z, Mai J, et al. Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophages. Nat Commun. 2020;11(1):6298.","journal-title":"Nat Commun"},{"issue":"1","key":"1265_CR17","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s13046-021-02091-6","volume":"40","author":"X Wei","year":"2021","unstructured":"Wei X, Lou H, Zhou D, Jia Y, Li H, Huang Q, Ma J, Yang Z, Sun C, Meng Y, et al. TAGLN mediated stiffness-regulated ovarian cancer progression via RhoA\/ROCK pathway. J Exp Clin Cancer Res. 2021;40(1):292.","journal-title":"J Exp Clin Cancer Res"},{"issue":"Suppl","key":"1265_CR18","doi-asserted-by":"publisher","first-page":"4563","DOI":"10.1002\/cncr.32595","volume":"125","author":"R Arend","year":"2019","unstructured":"Arend R, Martinez A, Szul T, Birrer MJ. Biomarkers in ovarian cancer: to be or not to be. Cancer. 2019;125(Suppl):4563\u201372.","journal-title":"Cancer"},{"key":"1265_CR19","doi-asserted-by":"crossref","unstructured":"Xia L, Wang Y, Cai S, Xu M. DGAT1 Expression Promotes Ovarian Cancer Progression and Is Associated with Poor Prognosis. J Immunol Res 2021, 2021:6636791.","DOI":"10.1155\/2021\/6636791"},{"issue":"1","key":"1265_CR20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41419-020-03336-6","volume":"12","author":"S Zhao","year":"2021","unstructured":"Zhao S, Cheng L, Shi Y, Li J, Yun Q, Yang H. MIEF2 reprograms lipid metabolism to drive progression of ovarian cancer through ROS\/AKT\/mTOR signaling pathway. Cell Death Dis. 2021;12(1):18.","journal-title":"Cell Death Dis"},{"issue":"1","key":"1265_CR21","doi-asserted-by":"publisher","first-page":"107327482096891","DOI":"10.1177\/1073274820968914","volume":"27","author":"L Chen","year":"2020","unstructured":"Chen L, Wang R, Gao L, Shi W. Opa-Interacting protein 5 expression in human glioma tissues is essential to the Biological function of U251 Human malignant glioma cells. Cancer Control. 2020;27(1):1073274820968914.","journal-title":"Cancer Control"},{"issue":"9","key":"1265_CR22","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.prp.2017.07.029","volume":"213","author":"X He","year":"2017","unstructured":"He X, Ding X, Wen D, Hou J, Ping J, He J. Exploration of the pathways and interaction network involved in bladder cancer cell line with knockdown of Opa interacting protein 5. Pathol Res Pract. 2017;213(9):1059\u201366.","journal-title":"Pathol Res Pract"},{"key":"1265_CR23","doi-asserted-by":"publisher","first-page":"805552","DOI":"10.3389\/fimmu.2022.805552","volume":"13","author":"M Gong","year":"2022","unstructured":"Gong M, Li Y, Song E, Li M, Qiu S, Dong W, Yuan R. OIP5 is a Novel Prognostic Biomarker in Clear Cell Renal Cell Cancer correlating with Immune infiltrates. Front Immunol. 2022;13:805552.","journal-title":"Front Immunol"},{"key":"1265_CR24","unstructured":"Zheng J, Cui Y, Yang S, Wang Y, Qiu Y, Hu W. Opa interacting protein 5 promotes metastasis of nasopharyngeal carcinoma cells by promoting EMT via modulation of JAK2\/STAT3 signal european review for Medical and Pharmacological Sciences 2019."},{"issue":"24","key":"1265_CR25","doi-asserted-by":"publisher","first-page":"4684","DOI":"10.7150\/jca.27381","volume":"9","author":"D Wang","year":"2018","unstructured":"Wang D, Chen Z, Lin F, Wang Z, Gao Q, Xie H, Xiao H, Zhou Y, Zhang F, Ma Y, et al. OIP5 promotes growth, metastasis and chemoresistance to cisplatin in bladder Cancer cells. J Cancer. 2018;9(24):4684\u201395.","journal-title":"J Cancer"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-023-01265-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-023-01265-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-023-01265-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T08:14:01Z","timestamp":1700554441000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-023-01265-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,2]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1265"],"URL":"https:\/\/doi.org\/10.1186\/s13048-023-01265-4","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,2]]},"assertion":[{"value":"19 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Anhui Yijishan Hospital, and all the patients participating in this study had written the informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The manuscript has been approved for publication by all authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"185"}}